Advertisement

Topics

Janssen Alzheimer Immunotherapy Company Profile

18:12 EDT 22nd March 2019 | BioPortfolio

Alzheimer's disease (AD), the most common form of dementia, is a fatal, degenerative brain disease that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate and carry out daily activities, such as bathing and eating. As AD progresses, individuals may also experience changes in personality and behavior, such as anxiety, suspiciousness or agitation, delusions or hallucinations.


News Articles [2539 Associated News Articles listed on BioPortfolio]

Janssen Research & Development, LLC: The best of times and the worst of times for neurosciences

In this episode of PharmaTelevision News Review, filmed at #BIO 2012 in Boston, Fintan Walton talks to Husseini Manji, Global Therapeutic Area Head, Neuroscience, Janssen Research & Development, LLC. ...

Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents

Update (28/01/2019): MorphoSys faces defeat in its long-running legal battle with Genmab and Janssen, as the US District Court of Delaware has declared three of its cancer immunotherapy patents inva...

Interview: AC Immune CEO Reflects On Alzheimer's R&D Post-CREAD

The recent failure of the CREAD studies to show a therapeutic effect for crenezumab in Alzheimer’s disease stunned developers. However...   

J&J's Janssen Ends Two Aduro Cancer Collaborations Launched in 2014

Johnson & Johnson’s Janssen Biotech is terminating a pair of collaborations to develop lung and prostate cancer treatments with Aduro Biotech that were launched in 2014 and could have generated ...

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease

Neurofibrillary pathology composed of tau protein is closely correlated with severity and phenotype of cognitive impairment in patients with Alzheimer’s disease and non-Alzheimer’s tauopathies. Ta...

$JNJ Janssen Affiliate Cilag Enters Worldwide Collab and License Agreement with $ARGX for Cancer Immunotherapy Cusatuzumab. $300M upfront to $ARGX https://www.prnewswire.com/news-releases/janssen-affiliate-cilag-gmbh-international-enters-worldwide-collabo

$JNJ Janssen Affiliate Cilag Enters Worldwide Collab and License Agreement with $ARGX for Cancer Immunotherapy Cusatuzumab. $300M upfront to $ARGX

J&J's Janssen Inks Deal With Korea’s Yuhan for NSCLC Drug Valued at up to $1.25 Billion

Janssen agreed to pay Yuhan $50 million in upfront money. Yuhan said that Janssen will be responsible for the development of lazertinib. Janssen will also be responsible for manufacturing and commerci...

Frustrated Alzheimer’s researchers seek better lab mice – Nature.com

Nature.comFrustrated Alzheimer's researchers seek better lab miceNature.comSeveral projects are trying to develop animal models that more closely mimic how the brain disease affects people. Sara Reard...

Drugs and Medications [338 Associated Drugs and Medications listed on BioPortfolio]

Risperidone [wockhardt usa llc.]

These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...

Risperidone [wockhardt limited]

These highlights do not include all the information needed to use risperidone oral solution safely and effectively. See full prescribing information for risperidone oral solution. Risperidone Oral Sol...

Topiramate [a-s medication solutions]

These highlights do not include all the information needed to use topiramate tablets safely and effectively. See full prescribing information for topiramate tablets. TOPIRAMATE Tablets USP, for oral u...

Rivastigmine [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM.   RIVAS...

Topiramate [proficient rx lp]

These highlights do not include all the information needed to use TOPIRAMATE TABLETS safely and effectively. See full prescribing information for TOPIRAMATE TABLETS. TOPIRAMATE tablets, for oral useIn...

PubMed Articles [1311 Associated PubMed Articles listed on BioPortfolio]

Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.

Alzheimer's disease (AD) has been a global concern for years due to its severe implications that affects the quality of life of the patients. The available line of therapy for treating Alzheimer's inc...

An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer's disease-A cohort study of 95,442 individuals.

We tested the hypothesis that low plasma complement C3 is observationally and genetically associated with high risk of Alzheimer's disease.

Identify compounds's target against Alzheimer's disease based on silico approach.

Alzheimer's disease swept every corner of the globe and the number of patients worldwide has been rising. At present, there are as many as 30 million people with Alzheimer's disease in the world, and ...

Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.

The tau protein plays a central role in Alzheimer's disease (AD), and there is huge interest in measuring tau in blood and cerebrospinal fluid (CSF).

Broadening the impact of immunotherapy to pancreatic cancer: Challenges and opportunities.

Pancreatic ductal adenocarcinoma (PDAC) is projected to become the second deadliest cancer in the US by 2025 , with 5-year survival at less than 10% . In other recalcitrant cancers, immunotherapy has ...

Clinical Trials [1219 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder

The purpose of this study is to assess the usability of the Janssen Autism Knowledge Engine (JAKE) as a system to monitor clinical outcomes in autism spectrum disorder (ASD) (severe abnorm...

Dominantly Inherited Alzheimer Network (DIAN)

The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.

A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Rabeprazole from Idiazole 20mg DR tabs (GSK, Egypt)and PARIET 20 mg DR tabs (JANS...

Alzheimer and Sleep

The aim of the study is the analysis of two inhibitors of Ach-E: galantamine and donépézil in over 65 years' old patients suffering from Alzheimer disease (MMSE between 20 and 26) withou...

Alzheimer Prevention Trials Webstudy

The goal of the Alzheimer Prevention Trials (APT) Webstudy is to accelerate enrollment for Alzheimer's disease (AD) clinical trials by identifying and tracking individuals who may be at hi...

Companies [435 Associated Companies listed on BioPortfolio]

Janssen Alzheimer Immunotherapy

Alzheimer's disease (AD), the most common form of dementia, is a fatal, degenerative brain disease that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate a...

Janssen Pharmaceuticals

Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is based in Titusville, N.J. and is the only large pharmaceutical company in the U.S. dedicated solely to mental health. It currently m...

Janssen-Cilag International NV

Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Janssen-Cilag EMEA, EMHF, ESHA & ISG

Janssen-Cilag EMEA, a division of Janssen Pharmaceutica N.V., is a research-based pharmaceutical company that develops and markets innovative, high-quality pharmaceutical products and services aim...

More Information about "Janssen Alzheimer Immunotherapy" on BioPortfolio

We have published hundreds of Janssen Alzheimer Immunotherapy news stories on BioPortfolio along with dozens of Janssen Alzheimer Immunotherapy Clinical Trials and PubMed Articles about Janssen Alzheimer Immunotherapy for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Janssen Alzheimer Immunotherapy Companies in our database. You can also find out about relevant Janssen Alzheimer Immunotherapy Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record